VILIN BIO MED LIMITED Financial Ratios
VILINBIO · Healthcare · Current price ₹47
P/E ratio
293.8x
P/B ratio
2.3x
ROE
7.5%
ROCE
4.2%
Debt / Equity
0.11
Dividend yield
0.0%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 293.8x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 2.3x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 7.5% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 4.2% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.11 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with VILIN BIO MED LIMITED's latest numbers.
VILIN BIO MED LIMITED profitability
VILIN BIO MED LIMITED generates a return on equity of 7.5% and a return on capital employed of 4.2%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.11 and a P/E of 293.8x, VILIN BIO MED LIMITED is conservatively financed. Our overall business-quality score for the company is 4.1 / 10.
Understand the ratios
More on VILIN BIO MED LIMITED
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.